Bioinformatics, Immune Response and Medical Schools

Not all neoantigens are created equal

Drug Target Review

DECEMBER 28, 2023

These neoantigens are identified by T cells of the immune system as foreign proteins and thus trigger an immune response. Recent advances in bioinformatics show clonal neoantigens are the best targets for immunotherapy, as I will elucidate below. Neoantigens are recognised as non-self and trigger an immune response.

Bioinformatics

Bioinformatics Immune Response DNA Vaccine

Accelerating Drug Discovery Through Repurposing

DrugBank

FEBRUARY 12, 2025

In Silico Drug Repurposing Advances in bioinformatics and systems biology have fueled the rise of repurposing of in silico drugs. For example, researchers at Harvard Medical School explored the association between the use of anti-inflammatory medications and the risk of developing Parkinson's disease.

Cell Based Assays

Cell Based Assays Drugs Pharmacokinetics Disease

Drug Discovery Digest

Not all neoantigens are created equal

Accelerating Drug Discovery Through Repurposing

Webinars

Stay Connected